Correction: Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial.

Correction: Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial.

Show other versions (1)

Bibliographic Details
Main Authors:	Sergio Serrano-Villar, Talia Sainz, Zhong-Min Ma, Netanya S Utay, Tae-Wook Chun, Surinder Mann, Angela D Kashuba, Basile Siewe, Anthony Albanese, Paolo Troia-Cancio, Elizabeth Sinclair, Anoma Somasunderam, Tammy Yotter, Steven G Deeks, Alan Landay, Richard B Pollard, Christopher J Miller, Santiago Moreno, David M Asmuth
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2016-03-01
Series:	PLoS Pathogens
Online Access:	https://doi.org/10.1371/journal.ppat.1005540

Similar Items

Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial.
by: Sergio Serrano-Villar, et al.
Published: (2016-01-01)

Correction: Effects of Combined CCR5/Integrase Inhibitors-Based Regimen on Mucosal Immunity in HIV-Infected Patients Naïve to Antiretroviral Therapy: A Pilot Randomized Trial.
by: Sergio Serrano-Villar, et al.
Published: (2017-05-01)

Adiponectin and the steatosis marker Chi3L1 decrease following switch to raltegravir compared to continued PI/NNRTI-based antiretroviral therapy.
by: Obiageli Offor, et al.
Published: (2018-01-01)

Serum Bovine Immunoglobulins Improve Inflammation and Gut Barrier Function in Persons with HIV and Enteropathy on Suppressive ART
by: Netanya Sandler Utay, et al.
Published: (2019-05-01)

Circulating LOXL2 Levels Reflect Severity of Intestinal Fibrosis and GALT CD4+ T Lymphocyte Depletion in Treated HIV Infection
by: Sophie Seang, et al.
Published: (2017-06-01)

HIV-2 integrase variation in integrase inhibitor-naïve adults in Senegal, West Africa.
by: Geoffrey S Gottlieb, et al.
Published: (2011-01-01)

MRSA Infections in HIV-Infected People Are Associated with Decreased MRSA-Specific Th1 Immunity.
by: Netanya S Utay, et al.
Published: (2016-04-01)

Regulatory B cells inhibit cytotoxic T lymphocyte (CTL) activity and elimination of infected CD4 T cells after in vitro reactivation of HIV latent reservoirs.
by: Basile Siewe, et al.
Published: (2014-01-01)

Evaluation of Six Weekly Oral Fecal Microbiota Transplants in People with HIV
by: Netanya Sandler Utay, et al.
Published: (2020-12-01)

Integrase and integration: biochemical activities of HIV-1 integrase
by: Deprez Eric, et al.
Published: (2008-12-01)

Neurological Response to cART vs. cART plus Integrase Inhibitor and CCR5 Antagonist Initiated during Acute HIV.
by: Victor G Valcour, et al.
Published: (2015-01-01)

Resistance to Integrase Inhibitors
by: Mathieu Métifiot, et al.
Published: (2010-06-01)

Relationship between HIV integrase polymorphisms and integrase inhibitor susceptibility: An in silico analysis
by: Hotma Martogi Lorensi Hutapea, et al.
Published: (2018-12-01)

HIV integrase variability and genetic barrier in antiretroviral naïve and experienced patients
by: Comolli Giuditta, et al.
Published: (2011-03-01)

Prototype Foamy Virus Integrase Displays Unique Biochemical Activities among Retroviral Integrases
by: Anthony J. Rabe, et al.
Published: (2021-12-01)

HIV-1 integrase tetramers are the antiviral target of pyridine-based allosteric integrase inhibitors
by: Pratibha C Koneru, et al.
Published: (2019-05-01)

Integrase-RNA interactions underscore the critical role of integrase in HIV-1 virion morphogenesis
by: Jennifer L Elliott, et al.
Published: (2020-09-01)

Evaluation of HIV-1 integrase resistance emergence and evolution in patients treated with integrase inhibitors
by: Rossana Scutari, et al.
Published: (2020-03-01)

Integrases, Aliens, & Bill Joy
by: Endy, Drew
Published: (2013)

Emergent dolutegravir resistance in integrase-naïve, treatment experienced patients from Zimbabwe
by: Linda A. Mandikiyana Chirimuta, et al.
Published: (2022-10-01)

GCN5-dependent acetylation of HIV-1 integrase enhances viral integration
by: Albanese Alberto, et al.
Published: (2010-03-01)

FcRL4 Expression Identifies a Pro-inflammatory B Cell Subset in Viremic HIV-Infected Subjects
by: Basile Siewe, et al.
Published: (2017-10-01)

A novel function for spumaretrovirus integrase: an early requirement for integrase-mediated cleavage of 2 LTR circles
by: Mouscadet Jean-François, et al.
Published: (2005-05-01)

Molecular evolution of HIV-1 integrase during the 20 years prior to the first approval of integrase inhibitors
by: Karolin Meixenberger, et al.
Published: (2017-11-01)

Multimodal Functionalities of HIV-1 Integrase
by: Alan N. Engelman, et al.
Published: (2022-04-01)

The impact of integrase inhibitors on steatosis and fibrosis biomarkers in persons with HIV naïve to antiretroviral therapy
by: Sara Rodrigues Fernandes, et al.
Published: (2023-08-01)

Drug-selective pressure effect on HIV integrase mutations in antiretroviral naïve and experienced patients
by: Parya Basimi, et al.
Published: (2023-04-01)

Mutations Located outside the Integrase Gene Can Confer Resistance to HIV-1 Integrase Strand Transfer Inhibitors
by: Isabelle Malet, et al.
Published: (2017-11-01)

CC Chemokines in a Tumor: A Review of Pro-Cancer and Anti-Cancer Properties of Receptors CCR5, CCR6, CCR7, CCR8, CCR9, and CCR10 Ligands
by: Jan Korbecki, et al.
Published: (2020-10-01)

Inhibition of HIV-1 integrase nuclear import and replication by a peptide bearing integrase putative nuclear localization signal
by: Waigmann Elisabeth, et al.
Published: (2009-12-01)

Systematic Assessment of Chemokine Signaling at Chemokine Receptors CCR4, CCR7 and CCR10
by: Herman D. Lim, et al.
Published: (2021-04-01)

Drug Resistance to HIV-1 Integrase Inhibitors Among Treatment-Naive Patients in Beijing, China
by: Yu F, et al.
Published: (2022-03-01)

Antagonist of chemokine receptors CCR1 and CCR3
by: Ammit Alaina, et al.
Published: (2000-11-01)

Multivalent interactions essential for lentiviral integrase function
by: Ballandras-Colas, A, et al.
Published: (2022)

Raltegravir: first in class HIV integrase inhibitor
by: Zelalem Temesgen, et al.
Published: (2008-06-01)

Structural and Functional Insights into Foamy Viral Integrase
by: Cha-Gyun Shin, et al.
Published: (2013-07-01)

HIV-1 integrase SUMOylation and viral replication
by: Engelman Alan, et al.
Published: (2011-10-01)

Multivalent interactions essential for lentiviral integrase function
by: Allison Ballandras-Colas, et al.
Published: (2022-05-01)

A New Freshwater Cyanosiphovirus Harboring Integrase
by: Kevin Xu Zhong, et al.
Published: (2018-09-01)

Biochemical characterization of novel retroviral integrase proteins.
by: Allison Ballandras-Colas, et al.
Published: (2013-01-01)